# Armata Pharmaceuticals, Inc.: Form 8-K, filed Aug 12, 2025

- Company: [Armata Pharmaceuticals, Inc.](/companies/armp.md) (CIK 921114)
- Form: 8-K
- Filed: 2025-08-12
- Accepted by EDGAR: Aug 12, 2025, 16:16 ET
- Period: 2025-08-11
- Accession: 0001558370-25-011227
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/921114/000155837025011227/armp-20250811x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921114/000155837025011227/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.02: Results of operations
- Item 2.03: New direct financial obligation
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921114/000155837025011227/armp-20250811x8k.htm

Filed Aug 12, 2025.
Source: SEC EDGAR, the filing index for accession 0001558370-25-011227. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.